NMD4C Welcomes Two New Staff Members
The NMD4C recently welcomed two new members to the network coordination team! Marine Christin, PhD joins us as the new Pre-Clinical Science Coordinator, and Maria Masnata, PhD joins as the Clinical Trials and Community of Practice Manager.
Marine Christin, PhD | Pre-Clinical Science Coordinator
After graduating with a BSc and an MSc in Pharmacology, Physiology, and Neurobiology, Marine Christin obtained her Ph.D. in Cellular and Molecular Interactions from Nice Sophia-Antipolis University. During her postdoctoral fellowship at McGill University, her research focused on investigating the role of ion channels in pain. Currently serving as the Program Manager for the McGill Regenerative Medicine Network, she oversees and coordinates research and educational activities within the Network.
Within the NMD4C, Marine oversees the coordination of the animal and cell-based research activities, including the basic research summer school.
Maria Masnata, PhD | Clinical Trials and Community of Practice Manager
Maria has over 10 years of experience in clinical and in preclinical research in the field of the Neurosciences. She received her M.Sc. in Pharmacy from University of Cagliari in 2015 and her Ph.D. in Neurobiology from Université Laval in 2021. Maria developed extensive experience in clinical research and project management during her previous role as the Assistant Manager of the Investigator-Initiated Trial team of the Clinical Research Unit at The Montreal Neurological Institute/Hospital (McGill University).
With a proven track record of managing and coordinating projects leading to Health Canada-approved clinical trials, peer-reviewed publications and national/international presentations, Maria is committed to advancing healthcare and advocating for scientific innovation in her role as Clinical Trials and Community of Practice Manager.
Read next...
NMD4C Receive Excellence in Service Delivery Award and Network Investigators Honored as part of Muscular Dystrophy Canada’s 2024 Dr David Green Awards
We are excited to share that the NMD4C has been awarded the Excellence in Service Delivery Award, one of the annual Dr David Green Awards presented by Muscular Dystrophy Canada.
NMD4C Launch Canadian Neuromuscular Clinical Trial Network
We are thrilled to announce the launch of a Canadian neuromuscular clinical trial network (CTN) as a part of our clinical research work.
Training Session for Physiotherapists and Occupational Therapists on Outcome Measures in Spinal muscular atrophy hosted by Quebec SMA Network
This past March 23, the Quebec SMA Network (Réseau québécois de l’amyotrophie spinale – RQAS) in collaboration with the NMD4C and Muscular Dystrophy Canada (MDC) hosted an interactive training session for French-speaking physiotherapists and occupational therapists on assessment measures and practices for Spinal muscular atrophy (SMA). This training gathered clinicians to train and discuss SMA standardized outcome measures and work through current problems/challenges, to improve how these measures often tied to drug reimbursement are conducted.
MDC Announce Recipients of 2024 Neuromuscular Clinical and Translational Research Grants
Muscular Dystrophy Canada (MDC) recently announced the recipients of its annual Neuromuscular Research Grants competition. Through these grants, MDC is investing $900,000 into clinical and translational research projects.
SMA Outcome Measures Training for Physiotherapists and Occupational Therapists
To support the development and training on validated NMD outcome measures we are pleased to provide opportunities for physiotherapists and occupational therapists to attend training sessions for outcome measures.
Congratulations to the 2024 NMD4C Early Career Awards Recipients
We are excited to announce the recipients of the 2024 NMD4C Early Career Awards! This is the second year of our annual award program, celebrating excellence and contribution to the neuromuscular field from early career investigators across both clinical and basic science streams.